AzTrials
AzTrials

Varicose VeinNCT00712517

Propofol Versus Volatile Anesthesia in Post Operative Pain Management

A study testing propofol and sevoflurane in people with Varicose Vein and Postoperative Pain, run by The Cleveland Clinic at 1 site in Austria.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The study will test the hypothesis that patients anesthetized with propofol suffer less postoperative pain than those anesthetized with sevoflurane. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Varicose Vein, Postoperative Pain
What is being tested?
propofol and sevoflurane
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteAustria
Study dates
Sep 2010to May 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants will undergo a stripping operation for varicose veins
  • Surgery will be performed by one physician only
  • Written informed consent

Who cannot join

  • Any contraindications to the proposed interventions
  • Procedures done under regional anesthesia

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Olga Plattner , MD

    Vienna

Other trials in Austria

About this study

Official title: Do Patients Anesthetized With Propofol Have Less Pain Than Those Anesthetized With Volatile?

The study will test the hypothesis that patients anesthetized with propofol suffer less postoperative pain than those anesthetized with sevoflurane.

Read the detailed description

Patients undergoing s stripping operation for varicose veins will be randomized to one of two groups. Group 1 patients will receive propofol anesthesia. Group 2 patients will receive sevoflurane anesthesia. Intraoperative measurements including mean-arterial pressure, heart rate, propofol infusion rate, remifentanil infusion rate, and end-tidal sevoflurane concentration will be taken at 15 minute intervals. Patients in both groups will receive Piritramid as necessary to control pain either intravenously or through patient controlled pump. VAS pain score, mean-arterial pressure, heart rate, nausea will be evaluated at 30 minute intervals during the first four postoperative hours. Piritramid dosage and vomiting will be recorded through the first postoperative morning. Patients will rate pain based on the VAS score for the period between leaving the recovery room and the first postoperative morning

Being tested
propofol, sevoflurane
Keywords
postoperative pain, Piritramid, propofol, sevoflurane, varicose vein, Anesthesia
Medical subject headings
Varicose Veins, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • propofolDrug

    Also called Diprivan

    propofol anesthesia 3-5mg/kg

  • sevofluraneDrug

    sevoflurane anesthesia

Study groups in NCT00712517
Study groupRoleWhat they receive
1Active comparatorPatients will receive propofol anesthesia during varicose vein stripping surgery.
Receives: Drug: propofol
2Active comparatorPatients will receive sevoflurane anesthesia during varicose vein stripping surgery.
Receives: Drug: sevoflurane

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome is morphine-equivalent use from the end of surgery until the first post-operative morning.

    Measured: first post operative morning

Secondary outcomes (1)
  1. To determine the average pain score for each group during the first four hours of recovery after surgery.

    Measured: 30 minute intervals for first 4 hours post operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2008 (estimated)
  2. Study startSep 2010
  3. Primary completionMay 2014
  4. Study completionMay 2014

Why it stopped: Enrolling of participants has halted and the results are being gathered

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00712517
Sponsor's protocol ID
42908
Status last verified
Jul 2016
First submitted
7 Jul 2008
Last updated
20 Jul 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Windpassinger M, Plattner O, Gemeiner J, Bohler K, Luntzer R, Klimscha W, Yang D, Mascha EJ, Sessler DI. Opioid use after propofol or sevoflurane anesthesia: a randomized trial. Can J Anaesth. 2016 Nov;63(11):1258-65. doi: 10.1007/s12630-016-0728-5. Epub 2016 Sep 14.

    PubMed 27638296

Questions about this trial

What is this clinical trial studying?

A study testing propofol and sevoflurane in people with Varicose Vein and Postoperative Pain, run by The Cleveland Clinic at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Enrolling of participants has halted and the results are being gathered). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome is morphine-equivalent use from the end of surgery until the first post-operative morning. (time frame: first post operative morning). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00712517, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in